Clinical Trials Directory

Trials / Unknown

UnknownNCT04923074

the Application of Diffusion Tensor Imaging in the Evaluation of Peripheral Neuropathy in ANCA Associated Vasculitis

the Application of Diffusion Tensor Imaging(DTI) in the Evaluation of Peripheral Neuropathy in Anti-neutrophil Cytoplasmic Antibodies Associated Vasculitis(AAV)

Status
Unknown
Phase
Study type
Observational
Enrollment
50 (estimated)
Sponsor
Second Affiliated Hospital, School of Medicine, Zhejiang University · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers

Summary

1. Include qualified 50 ANCA-associated vasculitis(AAV) patients; and the first 27 patients will be divided into 3 groups with different diffused tension image (DTI) parameters and to choose the best strategy; 2. On baseline, 6 months after treatment and 24 months after treatment, the AAV patients will accomplish the Birming-ham vasculitis activity score(BVAS) besides DTI; 3. The new serum biomarkers of AAV associated peripheral neuropathy will be measured by ELISA; (4) Another cohort with 50 patients with AAV associated peripheral neuropathy who were evaluated by traditional methods (electromyogram) and compared to the patients cohort that evaluated using DTI by cost-benefit analysis

Conditions

Interventions

TypeNameDescription
OTHERdiffusion tensor imaging(DTI) evaluationDTI is a new kind of MRI technique to evaluate peripheral neuropathy

Timeline

Start date
2021-07-01
Primary completion
2023-07-01
Completion
2023-07-01
First posted
2021-06-11
Last updated
2021-06-11

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT04923074. Inclusion in this directory is not an endorsement.